Avai Bio (AVAI) Accumulated Expenses (2018 - 2023)

Avai Bio has disclosed Accumulated Expenses across 6 years of filings, most recently posting $410000.0 for Q3 2023.

• Accumulated Expenses for Q3 2023 came in at $410000.0, up 157.05% year-over-year; the trailing twelve-month figure through Sep 2023 was $410000.0 (up 157.05% YoY), and the FY2023 annual result was $192600.0, up 0.84% from the prior year.
• Accumulated Expenses came in at $410000.0 for Q3 2023 at Avai Bio, down from $458600.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $458600.0 in Q2 2023 to a low of $355.0 in Q4 2021.
• The 5-year median for Accumulated Expenses is $90098.5 (2019), against an average of $130684.1.
• Across the five-year window, Accumulated Expenses sank 99.48% in 2020 and jumped 11957.58% in 2021, its largest moves.
• Avai Bio's Accumulated Expenses stood at $219795.0 in 2019, then tumbled by 99.48% to $1143.0 in 2020, then slumped by 68.94% to $355.0 in 2021, then jumped by 2742.82% to $10092.0 in 2022, then jumped by 3962.62% to $410000.0 in 2023.
• The last three Accumulated Expenses figures came in at $410000.0 (Q3 2023), $458600.0 (Q2 2023), and $192600.0 (Q1 2023), per Business Quant data.